Research Analysts’ updated eps estimates for Wednesday, August 7th:
Airbnb (NASDAQ:ABNB) had its hold rating reaffirmed by analysts at Needham & Company LLC.
AECOM (NYSE:ACM) had its buy rating reissued by analysts at Truist Financial Co.. Truist Financial Co. currently has a $108.00 price target on the stock, up from their previous price target of $107.00.
ADTRAN (NASDAQ:ADTN) had its neutral rating reiterated by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $6.00 target price on the stock.
Aeva Technologies (NYSE:AEVA) had its hold rating reissued by analysts at Westpark Capital.
agilon health (NYSE:AGL) had its outperform rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $8.00 target price on the stock.
Alto Ingredients (NASDAQ:ALTO) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $5.50 target price on the stock.
Amgen (NASDAQ:AMGN) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a $380.00 target price on the stock, up from their previous target price of $375.00.
ANI Pharmaceuticals (NASDAQ:ANIP) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $94.00 target price on the stock.
Archrock (NYSE:AROC) had its outperform rating reissued by analysts at Royal Bank of Canada. The firm currently has a $22.00 target price on the stock.
Axon Enterprise (NASDAQ:AXON) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $400.00 price target on the stock.
Azenta (NASDAQ:AZTA) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $69.00 target price on the stock.
Boise Cascade (NYSE:BCC) had its buy rating reissued by analysts at Truist Financial Co.. Truist Financial Co. currently has a $154.00 price target on the stock, down from their previous price target of $159.00.
Bicycle Therapeutics (NASDAQ:BCYC) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $38.00 target price on the stock.
Black Diamond Therapeutics (NASDAQ:BDTX) had its outperform rating reissued by analysts at Wedbush. They currently have a $16.00 target price on the stock.
Beam Therapeutics (NASDAQ:BEAM) had its sector perform rating reaffirmed by analysts at Royal Bank of Canada. The firm currently has a $27.00 price target on the stock.
B&G Foods (NYSE:BGS) had its sector perform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $10.00 price target on the stock.
Bowhead Specialty (NYSE:BOW) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. The firm currently has a $32.00 target price on the stock.
Bentley Systems (NASDAQ:BSY) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. The firm currently has a $61.00 target price on the stock.
Bentley Systems (NASDAQ:BSY) had its overweight rating reiterated by analysts at Piper Sandler. Piper Sandler currently has a $63.00 price target on the stock.
Bentley Systems (NASDAQ:BSY) had its buy rating reaffirmed by analysts at Rosenblatt Securities. The firm currently has a $62.00 price target on the stock.
Maplebear (NASDAQ:CART) had its hold rating reaffirmed by analysts at Needham & Company LLC.
Caterpillar (NYSE:CAT) had its buy rating reiterated by analysts at Truist Financial Co.. The firm currently has a $399.00 price target on the stock, up from their previous price target of $390.00.
Compass Therapeutics (NASDAQ:CMPX) had its outperform rating reiterated by analysts at Wedbush. The firm currently has a $8.00 price target on the stock.
Cogent Biosciences (NASDAQ:COGT) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $18.00 price target on the stock.
Traeger (NYSE:COOK) had its outperform rating reaffirmed by analysts at Telsey Advisory Group. They currently have a $4.00 price target on the stock.
Capita (LON:CPI) had its buy rating reaffirmed by analysts at Shore Capital.
Corbus Pharmaceuticals (NASDAQ:CRBP) had its outperform rating reiterated by analysts at Royal Bank of Canada. They currently have a $82.00 price target on the stock.
Caribou Biosciences (NASDAQ:CRBU) had its outperform rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $14.00 target price on the stock.
Dynavax Technologies (NASDAQ:DVAX) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $29.00 price target on the stock.
8X8 (NASDAQ:EGHT) had its buy rating reaffirmed by analysts at Rosenblatt Securities. They currently have a $4.00 price target on the stock.
Energizer (NYSE:ENR) had its sector perform rating reaffirmed by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $38.00 price target on the stock.
Exelixis (NASDAQ:EXEL) had its outperform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $27.00 target price on the stock.
Forterra (LON:FORT) had its hold rating reissued by analysts at Berenberg Bank. They currently have a GBX 170 ($2.17) target price on the stock.
4imprint Group (LON:FOUR) had its buy rating reissued by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 7,365 ($94.12) price target on the stock.
Fortinet (NASDAQ:FTNT) had its outperform rating reiterated by analysts at Wedbush. The firm currently has a $78.00 price target on the stock.
Fortinet (NASDAQ:FTNT) had its hold rating reissued by analysts at Needham & Company LLC.
fuboTV (NYSE:FUBO) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $2.00 target price on the stock.
First Watch Restaurant Group (NASDAQ:FWRG) had its hold rating reaffirmed by analysts at TD Cowen. TD Cowen currently has a $18.00 price target on the stock.
Goodwin (LON:GDWN) had its house stock rating reissued by analysts at Shore Capital.
The GEO Group (NYSE:GEO) had its outperform rating reiterated by analysts at Wedbush. The firm currently has a $19.00 price target on the stock.
GLOBALFOUNDRIES (NASDAQ:GFS) had its hold rating reiterated by analysts at Needham & Company LLC.
GLOBALFOUNDRIES (NASDAQ:GFS) had its outperform rating reaffirmed by analysts at Wedbush. The firm currently has a $65.00 target price on the stock.
Globus Medical (NYSE:GMED) had its hold rating reaffirmed by analysts at Needham & Company LLC.
Home Depot (NYSE:HD) had its market perform rating reiterated by analysts at Telsey Advisory Group. They currently have a $360.00 price target on the stock.
Heartland BancCorp (OTCMKTS:HLAN) had its neutral rating reiterated by analysts at DA Davidson. DA Davidson currently has a $145.00 price target on the stock, up from their previous price target of $103.00.
Heartland BancCorp (OTC:HLAN) had its neutral rating reiterated by analysts at DA Davidson. The firm currently has a $145.00 price target on the stock, up from their previous price target of $103.00.
Heron Therapeutics (NASDAQ:HRTX) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $5.00 target price on the stock.
IDEAYA Biosciences (NASDAQ:IDYA) had its outperform rating reaffirmed by analysts at Wedbush. Wedbush currently has a $54.00 target price on the stock.
IDEAYA Biosciences (NASDAQ:IDYA) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $61.00 target price on the stock.
Information Services Group (NASDAQ:III) had its outperform rating reissued by analysts at Barrington Research. They currently have a $3.50 target price on the stock.
Illumina (NASDAQ:ILMN) had its outperform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $242.00 target price on the stock.
Immuneering (NASDAQ:IMRX) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $15.00 price target on the stock.
Inogen (NASDAQ:INGN) had its hold rating reiterated by analysts at Needham & Company LLC.
Inspire Medical Systems (NYSE:INSP) had its outperform rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $260.00 price target on the stock.
Intra-Cellular Therapies (NASDAQ:ITCI) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $100.00 target price on the stock.
Jacobs Solutions (NYSE:J) had its hold rating reiterated by analysts at Truist Financial Co.. Truist Financial Co. currently has a $158.00 target price on the stock, up from their previous target price of $153.00.
JELD-WEN (NYSE:JELD) had its underperform rating reissued by analysts at Royal Bank of Canada. They currently have a $13.00 target price on the stock.
Karyopharm Therapeutics (NASDAQ:KPTI) had its outperform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $3.00 price target on the stock.
Grand Canyon Education (NASDAQ:LOPE) had its outperform rating reiterated by analysts at Barrington Research. The firm currently has a $165.00 target price on the stock.
Lyft (NASDAQ:LYFT) had its hold rating reaffirmed by analysts at Needham & Company LLC.
Masimo (NASDAQ:MASI) had its hold rating reissued by analysts at Needham & Company LLC.
MultiPlan (NYSE:MPLN) had its neutral rating reiterated by analysts at Piper Sandler. Piper Sandler currently has a $1.00 target price on the stock, down from their previous target price of $2.00.
MicroVision (NASDAQ:MVIS) had its hold rating reissued by analysts at Westpark Capital.
Netcall (LON:NET) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 130 ($1.66) price target on the stock.
Neumora Therapeutics (NASDAQ:NMRA) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $23.00 target price on the stock.
Newpark Resources (NYSE:NR) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $12.00 price target on the stock.
Nyxoah (NASDAQ:NYXH) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $18.00 target price on the stock.
Omega Therapeutics (NASDAQ:OMGA) had its outperform rating reiterated by analysts at Wedbush. The firm currently has a $12.00 price target on the stock.
ON24 (NYSE:ONTF) had its hold rating reissued by analysts at Needham & Company LLC.
Vaxcyte (NASDAQ:PCVX) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $95.00 target price on the stock.
PetMed Express (NASDAQ:PETS) had its hold rating reaffirmed by analysts at Lake Street Capital. The firm currently has a $3.50 price target on the stock, down from their previous price target of $7.00.
Progyny (NASDAQ:PGNY) had its hold rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a $24.00 target price on the stock, down from their previous target price of $37.00.
Planet Fitness (NYSE:PLNT) had its outperform rating reaffirmed by analysts at BMO Capital Markets. The firm currently has a $87.00 target price on the stock, up from their previous target price of $80.00.
Playa Hotels & Resorts (NASDAQ:PLYA) had its outperform rating reaffirmed by analysts at Macquarie. They currently have a $14.00 target price on the stock.
Qualys (NASDAQ:QLYS) had its hold rating reaffirmed by analysts at Needham & Company LLC.
Rathbones Group (LON:RAT) had its buy rating reissued by analysts at Shore Capital.
Redfin (NASDAQ:RDFN) had its neutral rating reissued by analysts at Wedbush. Wedbush currently has a $8.00 price target on the stock.
Redfin (NASDAQ:RDFN) had its hold rating reaffirmed by analysts at Needham & Company LLC.
Rivian Automotive (NASDAQ:RIVN) had its outperform rating reissued by analysts at Wedbush. The firm currently has a $20.00 target price on the stock.
Ralph Lauren (NYSE:RL) had its outperform rating reaffirmed by analysts at Telsey Advisory Group. The firm currently has a $195.00 target price on the stock.
Rightmove (LON:RMV) had its buy rating reaffirmed by analysts at Shore Capital.
Rapid7 (NASDAQ:RPD) had its hold rating reiterated by analysts at Needham & Company LLC.
Sunrun (NASDAQ:RUN) had its hold rating reaffirmed by analysts at Truist Financial Co.. Truist Financial Co. currently has a $18.00 target price on the stock, up from their previous target price of $12.00.
Revolve Group (NYSE:RVLV) had its neutral rating reaffirmed by analysts at Wedbush. Wedbush currently has a $19.00 price target on the stock.
Rhythm Pharmaceuticals (NASDAQ:RYTM) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $55.00 price target on the stock.
Starbucks (NASDAQ:SBUX) had its hold rating reissued by analysts at TD Cowen. TD Cowen currently has a $81.00 price target on the stock.
Semrush (NASDAQ:SEMR) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $18.00 price target on the stock.
Shoals Technologies Group (NASDAQ:SHLS) had its buy rating reaffirmed by analysts at Truist Financial Co.. Truist Financial Co. currently has a $10.00 price target on the stock, down from their previous price target of $12.00.
Steven Madden (NASDAQ:SHOO) had its neutral rating reiterated by analysts at Wedbush. Wedbush currently has a $41.00 price target on the stock.
Skyward Specialty Insurance Group (NASDAQ:SKWD) had its buy rating reaffirmed by analysts at Truist Financial Co.. Truist Financial Co. currently has a $49.00 target price on the stock, up from their previous target price of $47.00.
Skyline Champion (NYSE:SKY) had its neutral rating reiterated by analysts at Wedbush. Wedbush currently has a $64.00 price target on the stock.
Solid Power (NASDAQ:SLDP) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $3.00 target price on the stock.
Super Micro Computer (NASDAQ:SMCI) had its buy rating reaffirmed by analysts at Rosenblatt Securities. They currently have a $1,300.00 price target on the stock.
Sensei Biotherapeutics (NASDAQ:SNSE) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $4.00 price target on the stock.
ONE Group Hospitality (NASDAQ:STKS) had its overweight rating reaffirmed by analysts at Stephens. Stephens currently has a $9.00 price target on the stock.
Stellantis (NYSE:STLA) had its hold rating reiterated by analysts at Jefferies Financial Group Inc.. The firm currently has a $16.44 target price on the stock, down from their previous target price of $27.30.
TP ICAP Group (LON:TCAP) had its buy rating reaffirmed by analysts at Shore Capital.
Tempus AI (NASDAQ:TEM) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $47.00 price target on the stock.
Millicom International Cellular (NASDAQ:TIGO) had its sector perform rating reissued by analysts at Scotiabank. They currently have a $30.00 price target on the stock.
Toast (NYSE:TOST) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $30.00 target price on the stock.
The Property Franchise Group (LON:TPFG) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 589 ($7.53) price target on the stock.
Tripadvisor (NASDAQ:TRIP) had its neutral rating reissued by analysts at Wedbush. Wedbush currently has a $21.00 target price on the stock.
Uber Technologies (NYSE:UBER) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $90.00 target price on the stock.
Uber Technologies (NYSE:UBER) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $80.00 target price on the stock.
Upstart (NASDAQ:UPST) had its underperform rating reiterated by analysts at Wedbush. They currently have a $10.00 target price on the stock.
Universal Technical Institute (NYSE:UTI) had its outperform rating reaffirmed by analysts at Barrington Research. The firm currently has a $22.00 target price on the stock.
Universal Technical Institute (NYSE:UTI) had its buy rating reissued by analysts at Rosenblatt Securities. The firm currently has a $22.00 target price on the stock.
Veeco Instruments (NASDAQ:VECO) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $55.00 price target on the stock.
Voya Financial (NYSE:VOYA) had its outperform rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $83.00 target price on the stock.
V2X (NYSE:VVX) had its outperform rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $55.00 price target on the stock.
NCR Voyix (NYSE:VYX) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $20.00 target price on the stock.
Wix.com (NASDAQ:WIX) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $190.00 target price on the stock.
WPP (LON:WPP) had its buy rating reissued by analysts at Shore Capital.
Wolverine World Wide (NYSE:WWW) had its market perform rating reissued by analysts at Telsey Advisory Group. They currently have a $14.00 target price on the stock.
Wynn Resorts (NASDAQ:WYNN) had its outperform rating reissued by analysts at Macquarie. Macquarie currently has a $126.00 target price on the stock.
Clear Secure (NYSE:YOU) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $40.00 price target on the stock.
Clear Secure (NYSE:YOU) had its outperform rating reaffirmed by analysts at Telsey Advisory Group. They currently have a $34.00 price target on the stock.
Receive News & Ratings for Airbnb Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Airbnb Inc and related companies with MarketBeat.com's FREE daily email newsletter.
